Kevin McKenna
Labour - Sittingbourne and Sheppey
355 (0.9%) majority - 2024 General ElectionFirst elected: 4th July 2024
Division Voting information
Debates during the 2024 Parliament
Speeches made during Parliamentary debates are recorded in Hansard. For ease of browsing we have grouped debates into individual, departmental and legislative categories.
Sparring Partners
View All Sparring PartnersDepartment Debates
(2 debate contributions)
(2 debate contributions)
(1 debate contributions)
Legislation Debates
Kevin McKenna has not made any spoken contributions to legislative debateLatest EDMs signed by Kevin McKenna
Commons initiatives
These initiatives were driven by Kevin McKenna, and are more likely to reflect personal policy preferences.
MPs who are act as Ministers or Shadow Ministers are generally restricted from performing Commons initiatives other than Urgent Questions.
Kevin McKenna has not been granted any Urgent Questions
Kevin McKenna has not been granted any Adjournment Debates
Kevin McKenna has not introduced any legislation before Parliament
Kevin McKenna has not co-sponsored any Bills in the current parliamentary sitting
Latest 1 Written Question
(View all written questions)The Medicines and Healthcare products Regulatory Agency (MHRA) greatly welcomed the £10 million of funding announced by HM Treasury in March 2023, which has enabled the MHRA to make progress on the Innovative Licensing and Access Pathway (ILAP).
The ILAP harnesses the collective expertise of the regulatory and health technology assessment systems and National Health Service bodies, with the aim of supporting medicines from an early stage through to patient access more quickly. Since its launch in 2021, 166 Innovation Passports have been awarded.
The United Kingdom’s life sciences ecosystem within which the ILAP sits has evolved, with new regulatory initiatives such as the international recognition procedure. On Wednesday 6 November 2024, the ILAP partner organisations published a statement of policy intent on the relaunch of the ILAP. The new ILAP will continue to target timely patient benefit, take forward lessons learnt from the ILAP to date, and respond to the needs of our fast-paced life sciences sector by providing a more compelling offer of support to the medicine developer. The new ILAP will open to applications in March 2025, with full details of the pathway to be published in January 2025.
Minister of State (Department of Health and Social Care)